These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7439268)

  • 1. Digoxin dosage in renal insufficiency: impracticality of basing it on the creatinine clearance, body weight and volume of distribution.
    Keller F; Molzahn M; Ingerowski R
    Eur J Clin Pharmacol; 1980 Nov; 18(5):433-41. PubMed ID: 7439268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic aspects of digoxin in patients with terminal renal failure. IV. Clinical implications of own observations with a recent review of literature.
    van der Vijgh WJ; Oe PL
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):540-6. PubMed ID: 730421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin pharmacokinetics: role of renal failure in dosage regimen design.
    Koup JR; Jusko WJ; Elwood CM; Kohli RK
    Clin Pharmacol Ther; 1975 Jul; 18(1):9-21. PubMed ID: 1149366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].
    Ohnhaus EE; Spring P; Dettli L
    Dtsch Med Wochenschr; 1974 Sep; 99(37):1797-803. PubMed ID: 4457307
    [No Abstract]   [Full Text] [Related]  

  • 5. Digitalis therapy in renal failure with special regard to digitoxin.
    Vöhringer HF; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):175-84. PubMed ID: 7021432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Letter: Kinetics of elimination and dosage of digoxin in patients with kidney failure].
    Risler T
    Dtsch Med Wochenschr; 1974 Oct; 99(42):2130-1. PubMed ID: 4426236
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of plasma exchange on the steady-state kinetics of digoxin and digitoxin.
    Keller F; Kreutz G; Vöhringer HF; Offermann G; Distler A
    Clin Pharmacokinet; 1985; 10(6):514-23. PubMed ID: 4064450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digitalis pharmacokinetics and therapy with respect to impaired renal function.
    Kramer P
    Klin Wochenschr; 1977 Jan; 55(1):1-11. PubMed ID: 319291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of individual dosage of digoxin with calculated concentration.
    Zhao L; Yang P; Li P; Wang X; Qin W; Zhang X
    Clin Interv Aging; 2014; 9():1205-10. PubMed ID: 25092970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment.
    Okada RD; Hager WD; Graves PE; Mayersohn M; Perrier DG; Marcus FI
    Circulation; 1978 Dec; 58(6):1196-203. PubMed ID: 709776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proceedings: Clinical value of serum digoxin and digitoxin determination in renal insufficiency].
    Klauser-Reucker C; Ferrini B; Klauser H; Moccetti T
    Schweiz Med Wochenschr; 1975 Dec; 105(51):1784-6. PubMed ID: 1215979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of digoxin dosage in VLBW infants using serum creatinine concentrations.
    Gortner L; Hellenbrecht D
    Acta Paediatr Scand; 1986 May; 75(3):433-8. PubMed ID: 3728003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Digoxin dosing in the aged: new pharmacokinetic system versus Jellife and Koup methods].
    Cuena Boy R; Martín Montero Mdel P
    Invest Clin; 2003 Mar; 44(1):31-9. PubMed ID: 12703181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loading dose of digoxin in renal failure.
    Gault MH; Churchill DN; Kalra J
    Br J Clin Pharmacol; 1980 Jun; 9(6):593-7. PubMed ID: 7387815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of methods for estimating digoxin dosing regimens.
    Hyneck ML; Johnson MH; Wagner JG; Williams GW
    Am J Hosp Pharm; 1981 Jan; 38(1):69-73. PubMed ID: 7211872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of MDRD equation to detect occult renal failure and reduce the risk of digitalis overdose].
    Cepeda Piorno J; Pobes Martínez de Salinas A; González García ME; Fernández Rodríguez E
    Nefrologia; 2009; 29(2):150-5. PubMed ID: 19396321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Digoxin therapy in the aged under serum level control with special reference to hypertension].
    Gruber G; Pietruschka WD; Reuschel I; Sorger D; Günther K
    Z Gesamte Inn Med; 1980 Jan; 35(1):17-21. PubMed ID: 7405293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state concentrations and dosage of digoxin in relation to kidney function in hospitalized patients over 70 years of age.
    Algotsson A; Sanz E; Alván G
    J Intern Med; 1991 Mar; 229(3):247-51. PubMed ID: 2007843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic approaches to the use of digoxin in heart failure in patients with chronic end-stage renal failure].
    Kholodov LE; Glezer MG; Grigor'eva EA; Ksenzenko BL
    Kardiologiia; 1983 Jul; 23(7):103-5. PubMed ID: 6620803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.